Literature DB >> 2233893

In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens.

N A Rotowa1, H J Shadomy, S Shadomy.   

Abstract

Guidelines for the treatment of infections caused by unusual opportunistic fungi are limited and available in vitro data are scanty. In vitro susceptibility tests, employing an agar dilution procedure, were performed with amphotericin B (AMB), natamycin (NTC), itraconazole (ICZ), and ketoconazole (KTZ). Two media were used: Kimmig's agar (KA) and Yeast Morphology Agar (YMA). Fungi tested included isolates (n) of Acremonium spp. (10), Cunninghamella spp. (6), Fusarium spp. (18), Pseudallescheria boydii (14), and Trichosporon beigelii (5). All Acremonium and Cunninghamella isolates were susceptible to NTC (MIC less than or equal to 4 micrograms/ml) but many appeared to be resistant to AMB, (MIC greater than or equal to 32 micrograms/ml), KTZ and ICZ (MIC greater than or equal to 128 micrograms/ml). Most isolates of Fusarium spp. were susceptible to both AMB and NTC (MIC90 = 4 micrograms/ml); one isolate was cross-resistant to both polyenes (MIC greater than 32 micrograms/ml). Only two of 18 Fusarium isolates appeared susceptible to the imidazoles (MIC less than or equal to 4 micrograms/ml); the remaining isolates exhibited high MICs (greater than or equal to 64 micrograms/ml). All 14 isolates of P. boydii were susceptible to NTC (MIC less than or equal to 4 micrograms/ml) but four appeared to be resistant to AMB (MIC greater than or equal to 32 micrograms/ml). Most isolates of P. boydii were susceptible to both KTZ (MIC less than or equal to 4 micrograms/ml) and ICZ (MIC less than or equal to 16 micrograms/ml) but two isolates appeared to be resistant (MIC greater than or equal to 16 micrograms/ml).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2233893     DOI: 10.1111/myc.1990.33.4.203

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  12 in total

1.  In vitro and in vivo experimental activities of antifungal agents against Fusarium solani.

Authors:  J Guarro; I Pujol; E Mayayo
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Diagnosis of fusariosis in urine cytology.

Authors:  Cheng-Chuan Su; Hui-Jine Hsu; Jiunn-Jong Wu; Chien-Wen Chou
Journal:  J Clin Pathol       Date:  2006-06-30       Impact factor: 3.411

3.  Endophthalmitis caused by Fusarium proliferatum.

Authors:  Consuelo Ferrer; Jorge Alio; Alejandra Rodriguez; Mariano Andreu; Francisca Colom
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for amphotericin B fgainst Fusarium.

Authors:  I Pujol; J Guarro; J Sala; M D Riba
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

5.  Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient.

Authors:  Valérie Letscher-Bru; France Campos; Jocelyn Waller; Raoul Randriamahazaka; Ermanno Candolfi; Raoul Herbrecht
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

6.  Acremonium kiliense: reappraisal of its clinical significance.

Authors:  Ziauddin Khan; Khaled Al-Obaid; Suhail Ahmad; Amal Abdel Ghani; Leena Joseph; Rachel Chandy
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

Review 7.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 8.  Fusarium infections in immunocompromised patients: case reports and literature review.

Authors:  M Rabodonirina; M A Piens; M F Monier; E Guého; D Fière; M Mojon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

Review 9.  Taxonomy, biology, and clinical aspects of Fusarium species.

Authors:  P E Nelson; M C Dignani; E J Anaissie
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 10.  Opportunistic fusarial infections in humans.

Authors:  J Guarro; J Gené
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.